Ads
related to: modafinil and cataplexy pump for heart patients reviews- Stay Connected
Sign Up to Receive Important
Information & Updates on XYWAV.
- Sign Up for More Info
Receive Important Updates
About EDS/Cataplexy Treatment.
- Living With Narcolepsy
Learn How to Manage Living With
Your EDS and/or Cataplexy Today.
- Educational Webinars
Watch Experts Discuss Narcolepsy
Symptoms & a Treatment Option.
- Narcolepsy Health
Learn How to Treat Cataplexy
& or EDS in Narcolepsy.
- Doctor Discussion Guide
Talk to Your Doctor Today to
See if Treatment May Be an Option.
- Stay Connected
Search results
Results From The WOW.Com Content Network
Chemical structure of modafinil. This page lists chemical compounds similar to modafinil, known as modafinil analogues and derivatives. These are structural analogues and derivatives of modafinil, a drug that affects dopamine levels in the brain in an unusual way (atypical dopamine reuptake inhibitor or DRI).
In patients with acute signs of heart failure, small percutaneous (introduced to the heart through the skin into a blood vessel rather than through an incision) VADs such as the Impella 5.5, Impella RP, and others can be introduced to either the left or right ventricle (depending on the patient-specific needs) using a wire and that is ...
Impella heart pumps are percutaneous microaxial pumps that act as mechanical circulatory support devices in patients in need of hemodynamic support. [11] The pumps are mounted on support catheters and typically inserted through the femoral artery, although axillary and subclavian artery approaches are not uncommon. [12]
Eugeroics, in the sense of modafinil-type wakefulness promoting agents, include modafinil itself, armodafinil, and adrafinil, among others. [9] They are medically indicated for the treatment of certain sleep disorders , including excessive daytime sleepiness (EDS) in narcolepsy or obstructive sleep apnea (OSA).
Flmodafinil (developmental code names CRL-40,940, NLS-4, JBG01-41), also known as bisfluoromodafinil and lauflumide, is a wakefulness-promoting agent related to modafinil which has been developed for treatment of a variety of different medical conditions.
The FDA approved the OPTIMIZER Smart System, which delivers cardiac contractility modulation therapy, as indicated to improve 6-minute hall walk distance, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline directed medical therapy, who are in normal sinus rhythm, are not indicated for cardiac resynchronization therapy, and ...
Ad
related to: modafinil and cataplexy pump for heart patients reviews